For intravenous infusion: 4 grams in 250 mL of 5% Dextrose Injection, at a rate not exceeding 3 mL per minute. Serum magnesium levels should serve as a guide to continued dosage.

Magnesium Chloride Injection should not be administered if there is renal impairment, marked myocardial disease or to comatose patients.

Flushing, sweating, sharply lowered blood pressure, hypothermia, stupor and ultimately respiratory depression.

Magnesium Chloride Injection 200 mg/mL (20% w/v).

NDC 67457-134-50

50 mL Multiple-Dose Vial. Individually boxed.

Store at 20° to 25°C (68° to 77°F). [See USP Controlled

Room Temperature.]

Manufactured for:

Mylan Institutional LLC

Morgantown, WV 26505

Manufactured by:

Mylan Institutional

Galway, Ireland

1084L101

Revised: 10/2021

MI:MAGNIJ:R4

Magnesium Chloride Injection is a sterile solution of Magnesium Chloride Hexahydrate in Water for Injection q.s. Each mL contains Magnesium Chloride Hexahydrate 200 mg, Sodium Chloride 9 mg, Benzyl Alcohol 1% as a preservative, Water for Injection, q.s. pH adjusted with Hydrochloric Acid and/or Sodium Hydroxide. Total osmolarity equivalent to 2.951 mOsm/mL.

Contains 1.97 mEq of Mg⁺⁺ and Cl^- per mL.

The structural formula is MgCl₂•6H₂O

Magnesium is the second most plentiful cation within cellular fluids. It is an important activator of many enzyme systems and deficits are accompanied by a variety of functional disturbances.

Do not use if a precipitate is present.

Animal reproduction studies have not been conducted with magnesium chloride. It is also not known whether magnesium chloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Magnesium Chloride should be given to a pregnant woman only if clearly needed.

As an electrolyte replenisher in magnesium deficiencies.

The usual precautions for parenteral administration should be observed. Administer with caution if flushing and sweating occurs. A preparation of a calcium salt should be readily available for intravenous injection to counteract potential serious signs of magnesium intoxication. As long as deep tendon reflexes are active it is probable that the patient will not develop respiratory paralysis. Respiration and blood pressure should be carefully observed during and after administration of Magnesium Chloride Injection.

1 to 40 grams daily.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

NDC 67457-134-50     50 mL

Magnesium

Chloride

Injection

200 mg/mL

(20% w/v)

2.951 mOsm/mL

For Intravenous Use After

Dilution

Rx only Multiple-Dose Vial

Each mL contains: Magnesium

Chloride Hexahydrate 200 mg,

Sodium Chloride 9 mg, Benzyl

Alcohol 1% as a preservative,

Water for Injection q.s. pH adjusted

with Hydrochloric Acid and/or

Sodium Hydroxide.

Total osmolarity equivalent to

2.951 mOsm/mL.

Contains 1.97 mEq of Mg⁺⁺ and CI¯

per mL.

WARNING: DO NOT USE IF A

PRECIPITATE IS PRESENT.

Store at 20° to 25°C (68° to 77°F).

[See USP Controlled Room

Temperature.]

Usual Dosage: See accompanying

prescribing information.

Manufactured for:

Mylan Institutional LLC

Morgantown, WV 26505 U.S.A.

Manufactured by:

Mylan Institutional

Galway, Ireland

MI:134:1C:R5

Mylan.com

Magnesium is the second most plentiful cation within cellular fluids. It is an important activator of many enzyme systems and deficits are accompanied by a variety of functional disturbances.

Do not use if a precipitate is present.

Animal reproduction studies have not been conducted with magnesium chloride. It is also not known whether magnesium chloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Magnesium Chloride should be given to a pregnant woman only if clearly needed.

Magnesium Chloride Injection is a sterile solution of Magnesium Chloride Hexahydrate in Water for Injection q.s. Each mL contains Magnesium Chloride Hexahydrate 200 mg, Sodium Chloride 9 mg, Benzyl Alcohol 1% as a preservative, Water for Injection, q.s. pH adjusted with Hydrochloric Acid and/or Sodium Hydroxide. Total osmolarity equivalent to 2.951 mOsm/mL.

Contains 1.97 mEq of Mg⁺⁺ and Cl^- per mL.

The structural formula is MgCl₂•6H₂O

As an electrolyte replenisher in magnesium deficiencies.

The usual precautions for parenteral administration should be observed. Administer with caution if flushing and sweating occurs. A preparation of a calcium salt should be readily available for intravenous injection to counteract potential serious signs of magnesium intoxication. As long as deep tendon reflexes are active it is probable that the patient will not develop respiratory paralysis. Respiration and blood pressure should be carefully observed during and after administration of Magnesium Chloride Injection.

Magnesium Chloride Injection 200 mg/mL (20% w/v).

NDC 67457-134-50

50 mL Multiple-Dose Vial. Individually boxed.

Store at 20° to 25°C (68° to 77°F). [See USP Controlled

Room Temperature.]

Manufactured for:

Mylan Institutional LLC

Morgantown, WV 26505

Manufactured by:

Mylan Institutional

Galway, Ireland

1084L101

Revised: 10/2021

MI:MAGNIJ:R4

Flushing, sweating, sharply lowered blood pressure, hypothermia, stupor and ultimately respiratory depression.

Magnesium Chloride Injection should not be administered if there is renal impairment, marked myocardial disease or to comatose patients.

1 to 40 grams daily.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

For intravenous infusion: 4 grams in 250 mL of 5% Dextrose Injection, at a rate not exceeding 3 mL per minute. Serum magnesium levels should serve as a guide to continued dosage.

NDC 67457-134-50     50 mL

Magnesium

Chloride

Injection

200 mg/mL

(20% w/v)

2.951 mOsm/mL

For Intravenous Use After

Dilution

Rx only Multiple-Dose Vial

Each mL contains: Magnesium

Chloride Hexahydrate 200 mg,

Sodium Chloride 9 mg, Benzyl

Alcohol 1% as a preservative,

Water for Injection q.s. pH adjusted

with Hydrochloric Acid and/or

Sodium Hydroxide.

Total osmolarity equivalent to

2.951 mOsm/mL.

Contains 1.97 mEq of Mg⁺⁺ and CI¯

per mL.

WARNING: DO NOT USE IF A

PRECIPITATE IS PRESENT.

Store at 20° to 25°C (68° to 77°F).

[See USP Controlled Room

Temperature.]

Usual Dosage: See accompanying

prescribing information.

Manufactured for:

Mylan Institutional LLC

Morgantown, WV 26505 U.S.A.

Manufactured by:

Mylan Institutional

Galway, Ireland

MI:134:1C:R5

Mylan.com